Reproducibility of area at risk assessment in acute myocardial infarction by T1-and T2-mapping sequences in cardiac magnetic resonance imaging in comparison to Tc99m-Sestamibi SPECT 
Methods
We analyzed 14 patients undergoing primary coronary revascularization in AMI in whom both a pre-intervention Tc99m-Sestamibi-SPECT and CMR imaging at a median of 3.4 [3.3; 3.6] days after the acute event were performed. Size of AAR was measured by 4 different non-contrast CMR techniques on corresponding short axis slices: T2-weighted, fat-suppressed turbospin echo sequence (TSE), cine balanced FFE sequences in systolic phase (CINE), T2-mapping from T2-weighted balanced
FFE sequences (T2-MAP) and T1-mapping (MOLLI).
For each CMR sequence, the AAR was quantified by appropriate methods (absolute values for mapping sequences, comparison with remote myocardium or skeletal muscle for other sequences) and correlated with Tc99m-Sestamibi-SPECT. All measurements were performed on a 1.5 Tesla scanner.
Results
The size of the AAR assessed by CMR was 28.7±20.9 % of left ventricular myocardial volume (%LV) for TSE, 15.8 ±10.3 %LV for CINE, 39.5±16.8 %LV for T2-MAP, and 33.0±14.9 %LV for MOLLI. AAR assessed by SPECT measured 41.6 ±20.7 %LV. Correlation analysis revealed best correlation with SPECT for T2-MAP at a R2-threshold of 62.5 milliseconds (ms; slope=0.86, Pearson's r=0.93), for MOLLI at R1-threshold of 1100 ms (slope 0.72, r=0.9), and for TSE at 2 SD above remote (slope=0.65, r=0.86). CINE at 2 SD above remote had a similar correlation (r=0.87) but significantly underestimated AAR (slope 0.35, p<0.001 for difference in AAR size).
Conclusions
For the assessment of area at risk in AMI, the novel T2-mapping technique correlates best with SPECT size, T1-mapping with MOLLI and standard T2-weighted imaging show similar good correlations. 
